Pharma giant Merck announced this week that it plans to acquire Oncolmmune, a private held company, for $425 million in a cash transaction. The purchase would give Merck rights to an under the radar drug that has shown promising results in COVID-19 patients. Dubbed CD24Fc, the drug was shown to reduce the risk of respiratory … Continue reading “Merck to Acquire Oncolmmune to Gain Promising Corona Drug”
